• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Two Day Conference: Inhaled Drug Delivery - London, United Kingdom - November 6-7, 2019

Research and Markets Logo

News provided by

Research and Markets

Oct 24, 2019, 14:30 ET

Share this article

Share this article


DUBLIN, Oct. 24, 2019 /PRNewswire/ -- The "Inhaled Drug Delivery" conference has been added to ResearchAndMarkets.com's offering.

An essential annual update for inhalation professionals. Industry case studies, regulatory updates, latest therapies and technology innovations

Conference Overview

This seminar includes presentations and knowledge-sharing from world-recognised experts from industry, academia and regulation in the area of respiratory medicines and is an essential event for all those new to or experienced in inhaler drug delivery.

Inhaled drug delivery is achieved using four principal technologies: dry powder inhalers, metered-dose inhalers, nebulisers and liquid inhalers. Although there are many differences between these technologies, there are a number of fundamental principles that are followed to achieve an effective delivered dose. This event will provide an excellent forum to share knowledge and explore the opportunities across the dose forms with key industry leaders.

The most recent and innovative developments in inhaled drug delivery will be addressed including the use of triple therapies in lung disease, the development of long-awaited generic inhalers, the use of quality by design (QbD) principles in continuous manufacture, innovation in nebuliser treatment, reviews of connected devices, and the use of human factors in the design process. Regulations are key to respiratory medicines and future European and UK regulatory processes following Brexit will be critical when developing product approval strategies. Regulatory issues on this and other important hot topics will be considered.

This programme will provide valuable insights into inhaled drug delivery from experts in the field and will give you:

  • A comprehensive update on the advances in inhalation technology and inhaled drug delivery
  • An opportunity to keep abreast of global trends
  • An excellent forum to discuss challenges and how to overcome them
  • A chance to develop business relationships

Benefits of attending

  • Hear from an unrivalled faculty of speakers
  • Discover what is new in nebulised therapy
  • Explore new concepts in inhaled corticosteroid therapeutic equivalence
  • Gain new analytical insights into dry powder formulations for inhalation
  • Understand the challenges with triple combination inhalers
  • Consider the environment with inhaler devices
  • Discuss success criteria in technology transfer
  • Review new inhalation technologies
  • Hear about innovation in production technologies
  • Understand the regulatory requirements for respiratory products
  • Gain an insight into the regulatory position post Brexit
  • Learn about human factors and its relevance in product development
  • Explore opportunities with smart and digital inhalers

Agenda:

Programme Day One

DAY 1

Chair's welcome and introduction

Mike Holroyd

You can breathe easily now: modern respiratory medicines

  • Burden of respiratory diseases
  • The patient and the Quality Target Product Profile (for respiratory medicines)
  • Guidelines for lung disease treatment
  • Enhancements of older devices
  • Digital advancements for patients

Helen Muirhead

Innovation in nebulised therapy

  • How nebulised therapy is growing faster than other inhaled dosage forms, albeit from a smaller base
  • A review of the significant unmet medical needs for patients that would benefit from nebulised therapy
  • The potential commercial advantages to develop nebulised therapies ahead of the corresponding inhaler
  • The use of electronics to facilitate the introduction of patient management solutions

Dr John Pritchard

New concepts for inhaled corticosteroid therapeutic equivalence

  • Potency and clinical efficacy
  • Dose response
  • Duration of action
  • Therapeutic index

Peter Daly-Yates

INFORM 2020: new analytical insights into dry powder formulations for inhalation

  • Structural equivalence for inhaled formulations
  • Microstructural analytical techniques
  • Multi-scale computed tomography approaches to look inside formulations
  • Identifying metrics of relevance to inhaled product performance

Professor Darragh Murnane

Developing triple combination inhalers

  • The challenges and opportunities

Enrico Zambelli

Bringing better inhaled drugs faster to market through functional respiratory imaging (FRI) and artificial intelligence (AI)

  • Conventional lung function tests fail to provide regional information on lung structure and function and regional information matters
  • FRI and AI yield clinically relevant regional information
  • FRI received FDA support as part of the Biomarker Qualification Program
  • FRI and AI can

- Facilitate the development of novel treatments in COPD
- Assist in tackling environmental challenges such as wildfire exposure

Jan de Backer

Digitally enabled inhalers - a clinician's perspective

  • Types of technology that could be included in inhalers
  • The value of digital inhaler monitoring

Richard Costello

Technology transfer (TT) for inhaled drugs

  • TT requirements per ICH Q10
  • Regulatory (FDA, EU, WHO, Japan) and industry guidance for TT
  • Where TT fits in the product life cycle
  • Importance of critical quality attributes and control strategy
  • Implications for transfer of manufacture to or between third parties
  • Success criteria
  • Analytical method transfers

Bruce Davis

Discussion session

Programme Day two

Review of day one

Helen Muirhead

Review of new inhalation technologies

  • What is there to get excited about?
  • New innovations
  • Challenges in delivering inhaled dosage forms
  • Novel delivery platforms

Mike Holroyd

How to navigate a smooth regulatory pathway for inhaled products

  • Leveraging pre-submission advice to build a robust development plan
  • Crafting' a strong regulatory submission
  • Understanding what regulatory assessors are looking for
  • Managing the current regulatory hot topics' for inhaled products

Ian Ashurst

Regulatory alignment between the UK and Europe post Brexit

  • Latest position on Brexit
  • Implications for EU 27 and for UK inhaled products
  • Future role for the MHRA
  • Introduction of Regulation 3027/746 and Article 117 on combination products

Dr David Jefferys

Human factors (HF) studies - a hype or a must-do?

  • Legal and regulatory guidelines covering human factors for pharmaceutical products
  • HF and risk management
  • HF and clinical trials
  • Generic combination products - ANDAs and HF
  • Questions and challenges

Richard Featherstone

Handling fourses for the different use of inhalered devices

  • Human factors engineering (HFE): Do we need tick-boxes for inspectors or real-world data?
  • HFE is important for the patient
  • Can we test before the design process has started?
  • Is the concept of formative testing and confirmative / validation testing still up-to-date?
  • The need for quantitative data as guidelines for the engineering process

Dr Herbert Wachtel

Inhaler devices and the environment

  • Carbon footprints, an overview of the situation
  • Where next for the MDIs and HFAs?

Chris Baron

Could smart inhalers dramatically change the way that asthma and COPD patients are treated?

  • The burden of asthma and COPD remains high despite many new medicines
  • A major factor is poor adherence
  • Smart inhalers are being developed to monitor the way that patients use their inhalers
  • Can the data from smart inhalers improve patient-clinician communication?
  • Can smart inhalers improve adherence and ultimately lead to better health outcomes?

Alison Moore

Chair's closing remarks

For more information about this conference visit https://www.researchandmarkets.com/r/e5q8w5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Modal title

Also from this source

Asia Mobile Gaming Markets Report 2023-2028: Growing Demand of Local Content, Freemium Monetization, Cross-Platform Publishing to Augment Growth

Asia Mobile Gaming Markets Report 2023-2028: Growing Demand of Local Content, Freemium Monetization, Cross-Platform Publishing to Augment Growth


Global Human Machine Interface (HMI) Market Report 2022 to 2030: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts

Global Human Machine Interface (HMI) Market Report 2022 to 2030: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts

Explore

More news releases in similar topics

  • Publishing & Information Services
  • Medical Pharmaceuticals
  • Health Care & Hospitals
  • Surveys, Polls and Research

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.